Two Sigma Securities, LLC Novavax Inc Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$6.67 - $9.52 $75,951 - $108,404
11,387 New
11,387 $84,000
Q2 2022

Aug 15, 2022
SELL
$36.28 - $75.29 $291,618 - $605,181
-8,038 Reduced 43.63%
10,385 $534,000
Q1 2022

May 16, 2022
BUY
$69.73 - $142.9 $1.16 Million - $2.37 Million
16,600 Added 910.59%
18,423 $1.36 Million
Q4 2021

Feb 14, 2022
BUY
$134.56 - $217.97 $245,302 - $397,359
1,823 New
1,823 $261,000

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email